Breaking news

Elon Musk Seeks Meta Financing for Bold $97.4 Billion OpenAI Bid Amid Legal Turmoil

In a high-stakes maneuver that underscores the tech giants’ growing rivalry in artificial intelligence, Elon Musk, the world’s richest person, has reportedly approached Meta CEO Mark Zuckerberg with a proposition to finance a $97.4 billion acquisition of OpenAI. Court filings released this week reveal the unfolding complexities in a dispute that has pitted former allies against one another.

Rivalry And Legal Intrigue

Musk, whose launch of xAI in 2023 signaled his intent to contend directly with OpenAI, originally floated the takeover proposal in February. His proposal was fueled by mounting frustrations as OpenAI, under CEO Sam Altman, began transitioning into a for-profit model—an evolution that has reportedly undermined Musk’s strategic vision, given his earlier contributions to and alignment with the non-profit origins of the company.

Counter Claims And Strategic Maneuvers

Legal filings indicate that OpenAI has accused Musk and his new venture of executing a “sham bid” that not only jeopardizes its operations but has also provoked a series of counter claims. The tech leader’s aggressive litigation tactics and relentless public criticism via social media have intensified the legal and reputational battle between the two camps.

Meta’s Strategic Position In AI

As part of its counter strategy, OpenAI has sought to subpoena Meta for documented communications regarding Musk’s bid. While Meta has declined to comment, its filing underscores a significant competitive investment in artificial intelligence, recently marked by the hiring of top-tier researchers and enticing lucrative compensation packages. These measures reflect Meta’s ambition to solidify its AI capabilities, directly challenging OpenAI’s market leadership.

The Larger Implications

This episode not only highlights an escalating legal confrontation but also illustrates the wider strategic contest among top tech companies as they vie for dominance in a rapidly evolving AI landscape. With billions of dollars at stake and reputations on the line, industry insiders view this clash as indicative of the transformative dynamics shaping the future of technology investments and corporate strategy.

As the legal proceedings continue in a federal court in Northern California, the tech world waits with bated breath to see whether this audacious move by Musk will recalibrate the balance of power in the AI sector, or if the counterclaims will establish a new paradigm for competitive litigation in Silicon Valley.

EU Records €220.5 Billion Pharmaceutical Trade Surplus In 2025

The European Union secured a historic trade surplus in medicinal and pharmaceutical products in 2025, according to a report from Eurostat. Export figures reached €366.2 billion while imports totaled €145.7 billion, leading to a surplus of €220.5 billion.

Robust Growth In Exports And Imports

Exports increased by 16.0% from €315.7 billion in 2024. Imports rose by 21.0% from €120.4 billion over the same period. The data show continued expansion in trade volumes across the sector.

Leading National Performances

Ireland recorded the highest exports to non-EU countries at €93.8 billion. Germany and Belgium followed with €67.9 billion and €38.5 billion, respectively. Italy led imports at €27.5 billion, with Belgium and Germany also recording significant volumes.

Global Trade Partnerships

The United States was the largest destination for EU exports, accounting for 43.8% or €160.6 billion. Switzerland followed with 16.3% (€59.7 billion), while the United Kingdom accounted for 5.6% (€20.6 billion). On the import side, the United States supplied 41.2% of total imports (€60.1 billion), followed by Switzerland at 28.4% (€41.4 billion) and China at 9.0% (€13.1 billion).

Aretilaw firm
The Future Forbes Realty Global Properties
eCredo
Uol

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter